We are live on ! Find out more

Medical Devices
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
INGN icon
76
Inogen
INGN
$187M
$187M $7.04 5.55%
STIM icon
77
Neuronetics
STIM
$158M
$158M $2.08 3.48%
MXCT icon
78
MaxCyte
MXCT
$148M
$148M $1.43 2.72%
QTRX icon
79
Quanterix
QTRX
$134M
$134M $2.84 1.79%
OWLT icon
80
Owlet
OWLT
$121M
$121M $4.15 1.19%
APYX icon
81
Apyx Medical
APYX
$102M
$102M $2.41 3.98%
STXS icon
82
Stereotaxis
STXS
$100M
$100M $0.9980 0.31%
NRXS icon
83
Neuraxis
NRXS
$95.4M
$95.4M $7.60 4.04%
NYXH icon
84
Nyxoah
NYXH
$83.7M
$83.7M $0.8220 8.16%
LUNG icon
85
Pulmonx
LUNG
$80.7M
$80.7M $1.88 2.73%
SERA icon
86
Sera Prognostics
SERA
$80.5M
$80.5M $2.04 0.49%
OM icon
87
Outset Medical
OM
$78.4M
$78.4M $4.17 2.96%
HYPR icon
88
Hyperfine
HYPR
$77M
$77M $0.7258 2.75%
LNSR icon
89
LENSAR
LNSR
$74M
$74M $6.02 5.8%
ECOR icon
90
electroCore
ECOR
$66.8M
$66.8M $7.41 0.82%
MBOT icon
91
Microbot Medical
MBOT
$63.3M
$63.3M $0.9419 0.19%
LUCD icon
92
Lucid Diagnostics
LUCD
$62.6M
$62.6M $0.3277 1.71%
MDAI icon
93
Spectral AI
MDAI
$48.3M
$48.3M $1.50 0.66%
SRTS icon
94
Sensus Healthcare
SRTS
$47.2M
$47.2M $2.87 0.35%
COCH icon
95
Envoy Medical
COCH
$46.1M
$46.1M $0.5959 7.91%
TELA icon
96
TELA Bio
TELA
$45.6M
$45.6M $1.01 6.48%
SNWV icon
97
SANUWAVE Health Inc
SNWV
$45.6M
$45.6M $5.30 0.75%
RPID icon
98
Rapid Micro Biosystems
RPID
$40.2M
$40.2M $0.8010 1.86%
ELUT icon
99
Elutia
ELUT
$38.2M
$38.2M $0.8615 4.7%
CVRX icon
100
CVRx
CVRX
$36.5M
$36.5M $1.37 0%
2 3
4
5 6

Medical Devices Stocks at a Glance

Medical device companies develop surgical equipment, implants, pacemakers, imaging systems, and other therapeutic machines. Procedure volumes drive recurring demand, with regulatory approvals and surgeon adoption creating high switching costs and durable franchises around installed bases.

There are 136 Medical Devices industry stocks tracked by Wall St. Rank, worth a combined $821B.

The largest by market cap are Abbott (ABT) at $177B, Medtronic (MDT) at $124B and Stryker (SYK) at $118B.

Among institutional investors, Alamar Biosciences (ALMR) drew the most net new fund positions in Q2 2026: 87 funds opened new positions.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.